BioSpace News Archive

Business

111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System

Following 111, Inc.'s strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone.

May 24, 2019
·
5 min read
Global BRAF Kinase Inhibitors Market 2019-2023 | High Target Affinity and Specificity of BRAF Kinase Inhibitors to Boost Growth | Technavio

The global BRAF kinase inhibitors market is expected to post a CAGR of over 8% during the period 2019-2023, according to the latest market research report by Technavio.

May 24, 2019
·
4 min read
Business

Campaign for Tobacco-Free Kids Honors Sachit Gali of Sarasota, FL, As Youth Advocate of the Year

Sachit Gali, 17, of Sarasota, FL, has been named a Youth Advocate of the Year by the Campaign for Tobacco-Free Kids.

May 24, 2019
·
1 min read
Business

Campaign for Tobacco-Free Kids Honors Sarah Ryan of Holbrook, MA, As National Youth Advocate of the Year

Sarah Ryan, 18, of Holbrook, MA, has been named the Barrie Fiske National Youth Advocate of the Year by the Campaign for Tobacco-Free Kids.

May 24, 2019
·
2 min read
Drug Development

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference

Company’s lead molecule shows significant seizure protection in an animal model of epilepsy

May 24, 2019
·
4 min read
Business

Tomas Blomquist - New CEO & President of Biotage

Biotage AB, – Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB.

May 24, 2019
·
2 min read
FDA

FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality

The U.S. Food and Drug Administration approved Zolgensma, the first gene therapy approved to treat children less than two years of age with spinal muscular atrophy, the most severe form of SMA and a leading genetic cause of infant mortality.

May 24, 2019
·
5 min read
BC Government Announces $2 Million for Arthritis Research at ARThritis Soirée

Arthritis Research Canada received exciting news at Wednesday night’s annual ARThritis Soirée – a $2 million funding announcement by Health Minister Adrian Dix.

May 24, 2019
·
2 min read
FDA

AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)

AveXis, a Novartis company, announced the US Food and Drug Administration has approved Zolgensma® for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy with bi-allelic mutations in the survival motor neuron 1 gene.

May 24, 2019
·
18 min read
Policy

Consumer Product Update - Have you inspected your metal bristle barbecue brush lately?

Millions of Canadians enjoy using their barbecues, especially during the warm summer months.

May 24, 2019
·
1 min read